TREATMENT OF DRUG-INDUCED AGRANULOCYTOSIS WITH RECOMBINANT GM-CSF

被引：29
|
作者：
PALMBLAD, J
JONSON, B
KANERUD, L
机构：
[1] SODER SJUKHUSET, DIV HEMATOL, S-10064 STOCKHOLM, SWEDEN
[2] SODER SJUKHUSET, DEPT MED 3, DIV RHEUMATOL, S-10064 STOCKHOLM, SWEDEN
来源：
JOURNAL OF INTERNAL MEDICINE | 1990年 / 228卷 / 05期
关键词：
agranulocytosis; growth factors;
D O I：
10.1111/j.1365-2796.1990.tb00275.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Abstract. A 53‐year male patient, treated for rheumatoid arthritis with sulphasalazine, developed a total agranulocytosis. When this state had prevailed for at least 10 d no bone marrow granulocyte progenitor cells were detectable. Intravenous GM‐CSF treatment was initiated 5 d later, and the patient recovered within the next 6 d. GM‐CSF treatment for severe agranulocytosis deserves further investigation. 1990 Blackwell Publishing Ltd
引用
收藏
页码：537 / 539
页数：3
相关论文
共 50 条
  • [21] Drug-induced agranulocytosis in rheumatology.: A study of 12 cases
    Serraj, K.
    Federici, L.
    Maloisel, F.
    Sibilia, J.
    Andres, E.
    ANNALES DE BIOLOGIE CLINIQUE, 2007, 65 (04) : 431 - 436
  • [22] HEMATOPOIETIC GROWTH-FACTORS FOR ANTITHYROID DRUG-INDUCED AGRANULOCYTOSIS
    GENET, P
    PULIK, M
    LIONNET, F
    BREMONT, C
    ANNALES D ENDOCRINOLOGIE, 1994, 55 (01) : 39 - 42
  • [23] Non-chemotherapy drug-induced agranulocytosis in a tertiary hospital
    Navarro-Martinez, R.
    Chover-Sierra, E.
    Cauli, O.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2016, 35 (03) : 244 - 250
  • [24] Drug-induced agranulocytosis in the Berlin case–control surveillance study
    Matthias Huber
    Frank Andersohn
    Elisabeth Bronder
    Andreas Klimpel
    Michael Thomae
    Christine Konzen
    Oliver Meyer
    Abdulgabar Salama
    Hubert Schrezenmeier
    Martin Hildebrandt
    Ernst Späth-Schwalbe
    Andreas Grüneisen
    Reinhold Kreutz
    Edeltraut Garbe
    European Journal of Clinical Pharmacology, 2014, 70 : 339 - 345
  • [25] Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management
    Nuno Vicente
    Luís Cardoso
    Luísa Barros
    Francisco Carrilho
    Drugs in R&D, 2017, 17 : 91 - 96
  • [26] State of Art of Idiosyncratic Drug-Induced Neutropenia or Agranulocytosis, with a Focus on Biotherapies
    Andres, Emmanuel
    Lorenzo Villalba, Noel
    Zulfiqar, Abrar-Ahmad
    Serraj, Khalid
    Mourot-Cottet, Rachel
    Gottenberg, Jacques-Eric
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (09)
  • [27] Life-Threatening Idiosyncratic Drug-Induced Agranulocytosis in Elderly Patients
    Emmanuel Andrès
    Esther Noel
    Jean-Emmanuel Kurtz
    Nourredine Henoun Loukili
    Georges Kaltenbach
    Frédéric Maloisel
    Drugs & Aging, 2004, 21 : 427 - 435
  • [28] Drug-induced agranulocytosis in the Berlin case-control surveillance study
    Huber, Matthias
    Andersohn, Frank
    Bronder, Elisabeth
    Klimpel, Andreas
    Thomae, Michael
    Konzen, Christine
    Meyer, Oliver
    Salama, Abdulgabar
    Schrezenmeier, Hubert
    Hildebrandt, Martin
    Spaeth-Schwalbe, Ernst
    Grueneisen, Andreas
    Kreutz, Reinhold
    Garbe, Edeltraut
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (03) : 339 - 345
  • [29] RECOMBINANT HUMAN GM-CSF - PRESENT CLINICAL-RESULTS AND POTENTIAL USE IN ONCOLOGIC AND HEMATOLOGIC DISORDERS
    JONES, TC
    BULLETIN DU CANCER, 1991, 78 (12) : 1155 - 1159
  • [30] Characteristics of Korean Patients with Antithyroid Drug-Induced Agranulocytosis: A Multicenter Study in Korea
    Kim, Hee Kyung
    Yoon, Jee Hee
    Jeon, Min Ji
    Kim, Tae Yong
    Shong, Young Kee
    Lee, Min Jin
    Kim, Bo Hyun
    Kim, In Joo
    Joung, Ji Young
    Kim, Sun Wook
    Chung, Jae Hoon
    Kang, Ho-Cheol
    ENDOCRINOLOGY AND METABOLISM, 2015, 30 (04) : 475 - 480
12345